4/26/24 12:50 | 4/25/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | M.d | 25 | 11.96 | 0 | 2 | 1 | 171 | D | | | | | | | | | | | | | | |
4/26/24 12:38 | 4/25/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | M.d | 10 | 11.96 | 0 | 1 | 2 | 47 | D | | | | | | | | | | | | | | |
4/26/24 09:48 | 4/25/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | M.d | 7 | 11.96 | 0 | 1 | 6 | 10 | D | | | | | | | | | | | | | | |
4/23/24 16:39 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wan Jerry | A1 | O | Principa | M.d | 0 | 0.00 | 0 | 6 | 135 | 10 | D | | | | | | | | | | | | | | |
4/23/24 16:35 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | DO | P,CMO | M.d | 0 | 0.00 | 0 | 16 | 114 | 31 | D | | | | | | | | | | | | | | |
4/23/24 16:31 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | M.d | 0 | 0.00 | 0 | 23 | 79 | 51 | D | | | | | | | | | | | | | | |
4/23/24 16:26 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | M.d | 0 | 0.00 | 0 | 25 | 35 | 96 | D | | | | | | | | | | | | | | |
4/17/24 16:30 | 4/15/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -21 | 61.24 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
4/17/24 12:04 | 4/17/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 124 | 12.36 | 0 | 10 | 28 | 46 | D | | | | | | | | | | | | | | |
4/16/24 18:18 | 4/12/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Buechler Kenneth F | CA | D | | M.d | 190 | 21.07 | 0 | 9 | 12 | 84 | D | | | | | | | | | | | | | | |
4/15/24 19:21 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 7,058 | 2.92 | 0 | 2,420 | 33 | 9,858 | M | | | | | | | | | | | | | | |
4/15/24 06:04 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Josh | CA | DO | CEO,P | P | 10 | 2.95 | 0 | 3 | 999% | 4 | D | | | | | | | | | | | | | | |
4/15/24 06:02 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P | 100 | 2.95 | 0 | 34 | 67 | 85 | D | | | | | | | | | | | | | | |
4/11/24 11:40 | 4/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | P | 98 | 13.06 | 0 | 8 | 54 | 21 | D | | | | | | | | | | | | | | |
4/10/24 16:18 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 156 | 12.51 | 0 | 13 | 71 | 30 | D | | | | | | | | | | | | | | |
4/10/24 14:25 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 284 | 12.36 | 0 | 23 | 18 | 152 | D | | | | | | | | | | | | | | |
4/8/24 15:28 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Burton Paul Frederick | IL | D | | M.d | 13 | 1.42 | 0 | 9 | New | 9 | D | | | | | | | | | | | | | | |
4/8/24 15:22 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lau Stanley K. | IL | D | | M.d | 13 | 1.42 | 0 | 9 | 10 | 100 | D | | | | | | | | | | | | | | |
4/8/24 15:07 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Intrater James | IL | D | | M.d | 13 | 1.42 | 0 | 9 | 14 | 72 | D | | | | | | | | | | | | | | |
4/8/24 14:59 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Oded | IL | D | | M.d | 13 | 1.42 | 0 | 9 | 14 | 72 | D | | | | | | | | | | | | | | |
3/19/24 16:30 | 3/15/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -1,200 | 60.00 | 0 | -20 | -15 | 114 | D | | | | | | | | | | | | | | |
3/15/24 16:30 | 3/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -21 | 60.48 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
3/11/24 16:30 | 3/7/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -1,117 | 61.96 | 0 | -18 | -15 | 103 | D | | | | | | | | | | | | | | |
3/8/24 11:24 | 3/6/24 | CATX | Perspective Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lantheus Alpha Therapy, LLC | MA | T | | P | 57,409 | 0.9500 | 0 | 60,431 | 107 | 116,773 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 3,424 | 422.45 | 0 | 8 | 311 | 11 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -4,526 | 558.44 | 0 | -8 | -43 | 11 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/5/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 345 | 245.79 | 0 | 1 | 18 | 9 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/5/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S.d | -790 | 562.98 | 0 | -1 | -13 | 9 | D | | | | | | | | | | | | | | |
3/7/24 16:30 | 3/5/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | M.dm | 67 | 16.30 | 0 | 4 | 8 | 58 | D | | | | | | | | | | | | | | |
3/7/24 16:30 | 3/5/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | S.dm | -262 | 64.06 | 0 | -4 | -7 | 58 | D | | | | | | | | | | | | | | |
3/6/24 17:15 | 3/4/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | M.d | 444 | 19.85 | 0 | 22 | 63 | 58 | D | | | | | | | | | | | | | | |
3/6/24 17:15 | 3/4/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | S.d | -1,465 | 65.42 | 0 | -22 | -28 | 58 | D | | | | | | | | | | | | | | |
3/6/24 16:49 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | P.d | 46 | 4.59 | 0 | 10 | 35 | 39 | D | | | | | | | | | | | | | | |
3/6/24 16:43 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P.d | 46 | 4.59 | 0 | 10 | 15 | 77 | D | | | | | | | | | | | | | | |
3/5/24 20:28 | 3/4/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | S | -6,130 | 65.31 | 0 | -94 | -13 | 631 | D | | | | | | | | | | | | | | |
3/5/24 16:10 | 3/4/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | S.d | -76 | 32.99 | 0 | -2 | -3 | 82 | D | | | | | | | | | | | | | | |
3/5/24 16:10 | 3/4/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S.d | -20 | 32.99 | 0 | -1 | -1 | 71 | D | | | | | | | | | | | | | | |
2/27/24 16:21 | 8/15/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grossman Paul David | CA | D | | P.m | 50 | 5.37 | 0 | 9 | New | 9 | D | | | | | | | | | | | | | | |
2/26/24 18:48 | 2/23/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Busky Joseph M | CA | O | CFO | P | 100 | 46.36 | 0 | 2 | 54 | 6 | I | | | | | | | | | | | | | | |
2/22/24 17:02 | 2/21/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 100 | 206.94 | 0 | 0 | 1 | 82 | D | | | | | | | | | | | | | | |
2/20/24 17:01 | 2/16/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | M.d | 100 | 206.94 | 0 | 0 | 9 | 6 | D | | | | | | | | | | | | | | |
2/20/24 17:00 | 2/15/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 100 | 206.94 | 0 | 0 | 1 | 49 | D | | | | | | | | | | | | | | |
2/16/24 17:58 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 244 | 0 | D | | | | | | | | | | | | | | |
2/16/24 17:58 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreck Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 88 | 1 | D | | | | | | | | | | | | | | |
2/16/24 17:57 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 9 | 11 | D | | | | | | | | | | | | | | |
2/16/24 17:57 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 2 | 4 | 48 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 4 | 5 | 82 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 15 | 7 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Johnson Michael Perkins | ME | O | EVP,CHRO | M.d | 0 | 0.00 | 0 | 0 | 999% | 0 | D | | | | | | | | | | | | | | |
2/16/24 17:55 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 6 | 12 | D | | | | | | | | | | | | | | |
2/16/24 17:55 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | M.d | 0 | 0.00 | 0 | 0 | 6 | 7 | D | | | | | | | | | | | | | | |
2/16/24 17:54 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 5 | 11 | D | | | | | | | | | | | | | | |
2/15/24 16:30 | 2/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -19 | 55.31 | 0 | 0 | -1 | 58 | D | | | | | | | | | | | | | | |
2/15/24 16:05 | 2/13/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jimenez Freddy A. | NJ | O | SVP,GC | M.d | 93 | 3.86 | 0 | 24 | 999% | 26 | D | | | | | | | | | | | | | | |
2/9/24 17:03 | 2/8/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | M.d | 608 | 62.00 | 0 | 10 | | 7 | D | | | | | | | | | | | | | | |
2/9/24 17:03 | 2/8/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | S.d | -4,705 | 573.87 | 0 | -8 | -55 | 7 | D | | | | | | | | | | | | | | |
2/9/24 17:01 | 2/7/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 3,303 | 141.60 | 0 | 23 | 95 | 48 | D | | | | | | | | | | | | | | |
2/9/24 17:01 | 2/7/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | S.d | -13,296 | 570.01 | 0 | -23 | -33 | 48 | D | | | | | | | | | | | | | | |
2/9/24 17:00 | 2/7/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 814 | 67.85 | 0 | 12 | 18 | 79 | D | | | | | | | | | | | | | | |
2/9/24 17:00 | 2/7/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -6,871 | 572.61 | 0 | -12 | -13 | 79 | D | | | | | | | | | | | | | | |
2/5/24 16:50 | 1/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Lau Stanley K. | IL | D | | M.d | 2 | 2.18 | 0 | 1 | 1 | 92 | D | | | | | | | | | | | | | | |
2/2/24 19:55 | 2/2/24 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | S | -105 | 49.54 | 0 | -2 | -2 | 93 | D | | | | | | | | | | | | | | |
1/30/24 20:31 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P.d | 0 | 0.00 | 0 | 2 | 4 | 61 | D | | | | | | | | | | | | | | |
1/18/24 17:48 | 1/16/24 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | M.d | 0 | 0.00 | 0 | 22 | 33 | 91 | D | | | | | | | | | | | | | | |
1/18/24 17:48 | 1/17/24 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | S.d | -438 | 50.42 | 0 | -9 | -9 | 91 | D | | | | | | | | | | | | | | |
1/18/24 16:30 | 1/16/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -19 | 56.01 | 0 | 0 | -1 | 59 | D | | | | | | | | | | | | | | |
1/10/24 16:15 | 1/8/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | S | -66 | 28.87 | 0 | -2 | -5 | 44 | D | | | | | | | | | | | | | | |
1/5/24 16:51 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S | -566 | 29.46 | 0 | -19 | -2 | 905 | D | | | | | | | | | | | | | | |
1/5/24 16:50 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S | -172 | 29.46 | 0 | -6 | -10 | 54 | D | | | | | | | | | | | | | | |
1/5/24 16:50 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | S | -163 | 29.46 | 0 | -6 | -11 | 46 | D | | | | | | | | | | | | | | |
1/5/24 16:49 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | S | -158 | 29.46 | 0 | -5 | -12 | 41 | D | | | | | | | | | | | | | | |
1/5/24 16:46 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hicks Derek | MA | O | EVP,Chie | S | -114 | 29.46 | 0 | -4 | -9 | 37 | D | | | | | | | | | | | | | | |
1/5/24 16:45 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | S | -112 | 29.46 | 0 | -4 | -7 | 51 | D | | | | | | | | | | | | | | |
1/5/24 16:44 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S | -136 | 29.50 | 0 | -5 | -10 | 41 | D | | | | | | | | | | | | | | |
1/4/24 16:05 | 1/2/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | M.d | 30 | 2.78 | 0 | 11 | 44 | 35 | D | | | | | | | | | | | | | | |
1/3/24 17:35 | 1/1/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 4 | 7 | 52 | D | | | | | | | | | | | | | | |
1/3/24 17:34 | 1/1/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 3 | 6 | 60 | D | | | | | | | | | | | | | | |
1/3/24 17:30 | 1/1/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 8 | 1 | 924 | D | | | | | | | | | | | | | | |
1/3/24 17:28 | 1/1/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 3 | 7 | 46 | D | | | | | | | | | | | | | | |
1/3/24 10:41 | 1/2/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eight Corp Ltd | Y8 | T | | S | -18 | 0.9000 | 0 | -20 | 0 | 12,005 | I | | | | | | | | | | | | | | |
1/2/24 18:10 | 12/31/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Oded | IL | D | | M.ad | 13 | 2.49 | 0 | 5 | 9 | 63 | D | | | | | | | | | | | | | | |
1/2/24 18:04 | 12/31/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Sim Brandon | IL | D | | M.d | 13 | 2.49 | 0 | 5 | 9 | 63 | D | | | | | | | | | | | | | | |
1/2/24 17:58 | 12/31/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Intrater James | IL | D | | M.d | 13 | 2.49 | 0 | 5 | 9 | 63 | D | | | | | | | | | | | | | | |
1/2/24 17:54 | 12/28/23 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | M.d | 2,141 | 47.34 | 0 | 45 | 142 | 77 | D | | | | | | | | | | | | | | |
1/2/24 17:49 | 12/31/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Oded | IL | D | | M.d | 13 | 2.49 | 0 | 5 | 9 | 63 | D | | | | | | | | | | | | | | |
1/2/24 17:40 | 12/31/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Lau Stanley K. | IL | D | | M.d | 16 | 2.49 | 0 | 7 | 8 | 91 | D | | | | | | | | | | | | | | |
12/20/23 10:31 | 12/15/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eight Corp Ltd | Y8 | T | | S | -15 | 0.7500 | 0 | -20 | 0 | 12,025 | I | | | | | | | | | | | | | | |
12/19/23 17:00 | 12/15/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -782 | 78.24 | 0 | -10 | -9 | 103 | D | | | | | | | | | | | | | | |
12/19/23 10:59 | 12/18/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8300 | 0 | 10 | 4 | 278 | D | | | | | | | | | | | | | | |
12/18/23 09:38 | 12/15/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.7700 | 0 | 10 | 4 | 268 | D | | | | | | | | | | | | | | |
12/15/23 16:30 | 12/13/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -26 | 75.62 | 0 | 0 | -1 | 59 | D | | | | | | | | | | | | | | |
12/14/23 09:11 | 12/13/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | NV | O | Secretar | P | 6 | 0.6000 | 0 | 10 | 1 | 1,086 | D | | | | | | | | | | | | | | |
12/11/23 08:51 | 12/8/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 7 | 0.6700 | 0 | 10 | 0 | 2,746 | D | | | | | | | | | | | | | | |
12/8/23 17:28 | 12/6/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Merchant Minh Hoang | TX | O | Secretar | S | -3 | 3.37 | 0 | -1 | -4 | 27 | I | | | | | | | | | | | | | | |
12/8/23 17:00 | 12/7/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 2,955 | 253.92 | 0 | 12 | | 10 | D | | | | | | | | | | | | | | |
12/8/23 17:00 | 12/7/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -6,072 | 521.79 | 0 | -12 | -54 | 10 | D | | | | | | | | | | | | | | |
12/6/23 17:21 | 12/6/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P | 17 | 3.36 | 0 | 5 | 9 | 59 | D | | | | | | | | | | | | | | |
12/6/23 17:01 | 12/4/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 1,068 | 79.54 | 0 | 13 | 20 | 79 | D | | | | | | | | | | | | | | |
12/6/23 17:01 | 12/4/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -3,657 | 513.05 | 0 | -7 | -8 | 79 | D | | | | | | | | | | | | | | |
12/5/23 16:19 | 12/1/23 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggsbee Richard Bryan | UT | O | CFO | S | -573 | 19.09 | 0 | -30 | -9 | 292 | D | | | | | | | | | | | | | | |
12/1/23 17:44 | 11/30/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gelhaus Ken | CA | O | Chief Co | P | 6 | 1.73 | 0 | 4 | 19 | 23 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 15 | 0.7700 | 0 | 20 | 1 | 2,601 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D | | P | 7 | 0.8000 | 0 | 9 | 2 | 428 | D | | | | | | | | | | | | | | |
11/27/23 10:28 | 11/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 8 | 0.7600 | 0 | 10 | 0 | 2,581 | D | | | | | | | | | | | | | | |
11/24/23 11:06 | 11/22/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 14 | 0.7100 | 0 | 20 | 1 | 2,571 | D | | | | | | | | | | | | | | |
11/20/23 16:30 | 11/16/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -102 | 67.96 | 0 | -2 | -2 | 89 | D | | | | | | | | | | | | | | |
11/17/23 10:01 | 11/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8100 | 0 | 10 | 4 | 258 | D | | | | | | | | | | | | | | |
11/15/23 16:32 | 11/13/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | S | -751 | 63.72 | 0 | -12 | -2 | 697 | D | | | | | | | | | | | | | | |
11/15/23 16:30 | 11/13/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -22 | 63.57 | 0 | 0 | -1 | 59 | D | | | | | | | | | | | | | | |
11/8/23 17:09 | 11/7/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 231 | 133.76 | 0 | 2 | 37 | 6 | D | | | | | | | | | | | | | | |
11/3/23 17:12 | 11/1/23 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggsbee Richard Bryan | UT | O | CFO | S | -471 | 15.69 | 0 | -30 | -9 | 322 | D | | | | | | | | | | | | | | |
11/3/23 16:24 | 10/31/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Lau Stanley K. | IL | D | | M | 2 | 0.3016 | 0 | 7 | 9 | 84 | D | | | | | | | | | | | | | | |
11/3/23 13:59 | 11/3/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | P | 32 | 16.06 | 0 | 2 | 8 | 27 | D | | | | | | | | | | | | | | |
11/2/23 16:42 | 10/31/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | | S | -6 | 23.90 | 0 | 0 | -2 | 12 | D | | | | | | | | | | | | | | |
10/26/23 08:01 | 10/25/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 152 | 15.17 | 0 | 10 | 38 | 36 | D | | | | | | | | | | | | | | |
10/17/23 10:06 | 10/13/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S | -5 | 15.10 | 0 | 0 | -1 | 27 | D | | | | | | | | | | | | | | |
10/13/23 17:03 | 6/2/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Baylor-Henry Minnie | MA | D | | S | -1 | 86.22 | 0 | 0 | -27 | 0 | I | | | | | | | | | | | | | | |
10/12/23 16:01 | 10/12/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 46 | 15.19 | 0 | 3 | 17 | 20 | D | | | | | | | | | | | | | | |
10/12/23 11:54 | 10/11/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | S | -40 | 15.61 | 0 | -3 | -10 | 25 | D | | | | | | | | | | | | | | |
10/12/23 11:25 | 10/11/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S | -30 | 15.69 | 0 | -2 | -7 | 26 | D | | | | | | | | | | | | | | |
10/11/23 16:21 | 10/11/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 150 | 15.03 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
10/4/23 12:15 | 7/31/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Lau Stanley K. | IL | D | | M.dm | 19 | 0.3859 | 0 | 48 | 163 | 77 | D | | | | | | | | | | | | | | |
10/4/23 11:39 | 9/30/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Oded | IL | D | | M.ad | 13 | 0.3400 | 0 | 37 | 175 | 58 | D | | | | | | | | | | | | | | |
10/4/23 11:34 | 9/30/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Intrater James | IL | D | | M.ad | 13 | 0.3400 | 0 | 37 | 175 | 58 | D | | | | | | | | | | | | | | |
10/4/23 11:27 | 9/30/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Sim Brandon | IL | D | | M.ad | 13 | 0.3400 | 0 | 37 | 175 | 58 | D | | | | | | | | | | | | | | |
10/3/23 18:01 | 9/30/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Oded | IL | D | | M.d | 13 | 0.3400 | 0 | 37 | 175 | 58 | D | | | | | | | | | | | | | | |
10/3/23 17:53 | 9/30/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Intrater James | IL | D | | M.d | 13 | 0.3400 | 0 | 37 | 175 | 58 | D | | | | | | | | | | | | | | |
10/3/23 17:45 | 9/30/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Sim Brandon | IL | D | | M.d | 13 | 0.3400 | 0 | 37 | 175 | 58 | D | | | | | | | | | | | | | | |
9/21/23 20:58 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Telegraph Hill Partners Iv, L.P. | CA | T | | P | 15,000 | 1.85 | 0 | 8,108 | 46 | 25,621 | M | | | | | | | | | | | | | | |
9/21/23 17:04 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrill Damon | CA | O | GC,CCO | P | 50 | 1.85 | 0 | 27 | 193 | 41 | D | | | | | | | | | | | | | | |
9/21/23 17:04 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mackowski J Matthew | CA | D | | P | 1,500 | 1.85 | 0 | 811 | 999% | 821 | I | | | | | | | | | | | | | | |
9/21/23 17:03 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | P | 100 | 1.85 | 0 | 54 | 159 | 88 | D | | | | | | | | | | | | | | |
9/21/23 17:03 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 100 | 1.85 | 0 | 54 | 50 | 163 | D | | | | | | | | | | | | | | |
9/19/23 16:30 | 9/15/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | M.d | 51 | 17.79 | 0 | 3 | 4 | 66 | D | | | | | | | | | | | | | | |
9/19/23 16:30 | 9/15/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S.d | -189 | 66.43 | 0 | -3 | -4 | 66 | D | | | | | | | | | | | | | | |
9/19/23 16:05 | 8/31/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Henshall Mickie | NV | D | | P | 5 | 1.25 | 0 | 4 | 25 | 19 | D | | | | | | | | | | | | | | |
9/12/23 18:37 | 9/8/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hombeck Torsten | TX | O | CFO | P | 10 | 4.30 | 0 | 2 | 298 | 3 | D | | | | | | | | | | | | | | |
9/8/23 12:18 | 8/25/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DOT | CEO | P.m | 10 | 0.5460 | 0 | 18 | 17 | 128 | I | | | | | | | | | | | | | | |
9/8/23 12:12 | 8/25/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.m | 10 | 0.5460 | 0 | 18 | 17 | 128 | D | | | | | | | | | | | | | | |
9/6/23 17:01 | 9/1/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 9 | 0 | D | | | | | | | | | | | | | | |
9/6/23 10:01 | 9/5/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Barnes Phillip | NV | D | | P | 7 | 1.30 | 0 | 5 | 25 | 25 | D | | | | | | | | | | | | | | |
9/5/23 17:01 | 8/31/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 1,068 | 79.54 | 0 | 13 | 23 | 73 | D | | | | | | | | | | | | | | |
9/5/23 17:01 | 8/31/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -6,873 | 512.01 | 0 | -13 | -16 | 73 | D | | | | | | | | | | | | | | |
9/5/23 16:14 | 8/24/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DOT | Chief Me | P.m | 20 | 0.5999 | 0 | 34 | 1 | 3,282 | I | | | | | | | | | | | | | | |
9/1/23 09:41 | 8/31/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | NV | D | | P | 12 | 1.28 | 0 | 10 | 0 | 2,030 | D | | | | | | | | | | | | | | |
8/31/23 17:17 | 8/29/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 2,438 | 144.21 | 0 | 17 | | 10 | D | | | | | | | | | | | | | | |
8/31/23 17:17 | 8/29/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -11,696 | 510.56 | 0 | -23 | -70 | 10 | D | | | | | | | | | | | | | | |
8/31/23 09:35 | 8/29/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P.m | 25 | 1.25 | 0 | 20 | 6 | 328 | I | | | | | | | | | | | | | | |
8/28/23 10:07 | 8/25/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 25 | 1.24 | 0 | 20 | 7 | 308 | D | | | | | | | | | | | | | | |
8/25/23 11:49 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kway Jasmine | NV | O | CEO - Si | P | 6 | 1.20 | 0 | 5 | 6 | 87 | I | | | | | | | | | | | | | | |
8/25/23 11:49 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D | | P | 6 | 1.22 | 0 | 5 | 1 | 419 | D | | | | | | | | | | | | | | |
8/24/23 17:58 | 8/24/23 | MYMD | Mymd Pharmaceuticals, Inc. | NJ | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | GC | P | 167 | 1.11 | 0 | 150 | 60 | 400 | D | | | | | | | | | | | | | | |
8/24/23 12:00 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Michel Gaetan | NV | O | COO | P | 6 | 1.23 | 0 | 5 | 2 | 213 | D | | | | | | | | | | | | | | |
8/23/23 16:30 | 8/21/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -27 | 66.10 | 0 | 0 | 0 | 90 | D | | | | | | | | | | | | | | |
8/22/23 16:30 | 8/18/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -98 | 65.19 | 0 | -2 | -2 | 90 | D | | | | | | | | | | | | | | |
8/22/23 10:57 | 8/18/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | M.d | 23 | 15.62 | 0 | 2 | 7 | 25 | D | | | | | | | | | | | | | | |
8/22/23 10:57 | 8/18/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | S.d | -34 | 22.59 | 0 | -2 | -6 | 25 | D | | | | | | | | | | | | | | |
8/18/23 16:21 | 8/17/23 | MYMD | Mymd Pharmaceuticals, Inc. | NJ | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | GC | P | 28 | 1.12 | 0 | 25 | 11 | 250 | D | | | | | | | | | | | | | | |
8/17/23 19:37 | 8/15/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | 0 | 0.00 | 0 | 0 | 0 | 596 | D | | | | | | | | | | | | | | |
8/17/23 16:30 | 8/15/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -685 | 68.52 | 0 | -10 | -8 | 108 | D | | | | | | | | | | | | | | |
8/17/23 09:40 | 8/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 10 | 1.21 | 0 | 8 | 3 | 254 | D | | | | | | | | | | | | | | |
8/16/23 12:28 | 8/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 12 | 1.22 | 0 | 10 | 0 | 2,536 | D | | | | | | | | | | | | | | |
8/15/23 17:35 | 8/11/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | S | -751 | 68.58 | 0 | -11 | -2 | 708 | D | | | | | | | | | | | | | | |
8/15/23 16:54 | 8/11/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S | -292 | 67.93 | 0 | -4 | -6 | 66 | D | | | | | | | | | | | | | | |
8/8/23 17:59 | 8/5/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 0 | 0 | 48 | D | | | | | | | | | | | | | | |
8/8/23 17:59 | 8/5/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 0 | 1 | 73 | D | | | | | | | | | | | | | | |
8/7/23 17:04 | 8/3/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 3,005 | 187.47 | 0 | 16 | | 5 | D | | | | | | | | | | | | | | |
8/7/23 17:04 | 8/3/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | S.d | -8,174 | 510.00 | 0 | -16 | -78 | 5 | D | | | | | | | | | | | | | | |
8/2/23 17:19 | 7/31/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | | S | -11 | 42.33 | 0 | 0 | -2 | 12 | D | | | | | | | | | | | | | | |
7/26/23 19:28 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fralick Celeste Rachelle | TX | D | | P | 3 | 3.98 | 0 | 1 | 7 | 12 | D | | | | | | | | | | | | | | |
7/26/23 16:28 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vos Ellen O'Connor | CT | D | | P | 15 | 3.98 | 0 | 4 | 13 | 33 | D | | | | | | | | | | | | | | |
7/25/23 17:39 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P | 500 | 2.75 | 0 | 182 | 11 | 1,884 | I | | | | | | | | | | | | | | |
7/25/23 17:20 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Stefanie L. | TX | D | | P | 25 | 3.98 | 0 | 6 | 22 | 35 | D | | | | | | | | | | | | | | |
7/25/23 17:16 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P | 50 | 3.98 | 0 | 13 | 10 | 135 | D | | | | | | | | | | | | | | |
7/25/23 17:11 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Phan Ryan Thinh | TX | O | CSO,COO | P | 2 | 3.98 | 0 | 1 | 19 | 4 | D | | | | | | | | | | | | | | |
7/25/23 17:03 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parnell Winfred | TX | D | | P | 25 | 3.98 | 0 | 6 | 25 | 32 | D | | | | | | | | | | | | | | |
7/25/23 16:58 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Merchant Minh Hoang | TX | O | GC,secre | P | 3 | 3.98 | 0 | 1 | 18 | 5 | M | | | | | | | | | | | | | | |
7/24/23 18:58 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jordan Veronica Gh | TX | D | | P | 15 | 3.98 | 0 | 4 | 12 | 35 | D | | | | | | | | | | | | | | |
7/24/23 18:53 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hombeck Torsten | TX | O | CFO | P | 3 | 3.98 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
7/24/23 18:49 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Herchuk Jannie Prestridge | TX | D | | P | 35 | 3.98 | 0 | 9 | 58 | 24 | D | | | | | | | | | | | | | | |
7/21/23 16:30 | 7/19/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -159 | 90.87 | 0 | -2 | -3 | 60 | D | | | | | | | | | | | | | | |
7/10/23 17:21 | 7/6/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | | S | -73 | 39.30 | 0 | -2 | -13 | 13 | D | | | | | | | | | | | | | | |
7/6/23 15:34 | 7/3/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S | -15 | 40.51 | 0 | 0 | -1 | 45 | D | | | | | | | | | | | | | | |
7/5/23 13:55 | 6/30/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Lau Stanley K. | IL | D | | M.dm | 35 | 1.19 | 0 | 29 | New | 29 | D | | | | | | | | | | | | | | |
7/5/23 13:19 | 6/30/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Intrater James | IL | D | | M.d | 25 | 1.19 | 0 | 21 | 999% | 21 | D | | | | | | | | | | | | | | |
7/5/23 13:13 | 6/30/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Sim Brandon | IL | D | | M.d | 25 | 1.19 | 0 | 21 | New | 21 | D | | | | | | | | | | | | | | |
7/5/23 13:04 | 6/30/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Oded | IL | D | | M.d | 25 | 1.19 | 0 | 21 | New | 21 | D | | | | | | | | | | | | | | |
6/26/23 10:27 | 4/25/23 | NYMX | Nymox Pharmaceutical Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Robinson James George | MD | DT | | P.am | 37 | 0.4600 | 0 | 80 | 2 | 4,782 | D | | | | | | | | | | | | | | |
6/22/23 17:52 | 6/20/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | M.d | 61 | 12.27 | 0 | 5 | 12 | 45 | D | | | | | | | | | | | | | | |
6/22/23 17:52 | 6/20/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S.d | -225 | 45.00 | 0 | -5 | -10 | 45 | D | | | | | | | | | | | | | | |
6/15/23 20:13 | 6/14/23 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Alfred D | NY | D | | P | 6 | 0.2149 | 0 | 30 | 6 | 563 | D | | | | | | | | | | | | | | |
6/14/23 16:55 | 6/13/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hood Lisa | CA | O | Chief Pe | S | -43 | 3.80 | 0 | -11 | -25 | 34 | D | | | | | | | | | | | | | | |
6/6/23 10:14 | 6/2/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 16 | 1.59 | 0 | 10 | 5 | 217 | D | | | | | | | | | | | | | | |
6/2/23 18:15 | 6/2/23 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Spiegelman Daniel K | UT | D | | S | -199 | 23.01 | 0 | -9 | -18 | 40 | D | | | | | | | | | | | | | | |
6/1/23 17:42 | 5/30/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P | 28 | 5.50 | 0 | 5 | 8 | 67 | D | | | | | | | | | | | | | | |
5/31/23 17:16 | 5/26/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Davis Ted | CA | DT | | P | 6 | 3.22 | 0 | 2 | 0 | 3,576 | D | | | | | | | | | | | | | | |
5/31/23 17:16 | 5/26/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Davis Irene | CA | DT | | P | 6 | 3.22 | 0 | 2 | 0 | 3,576 | I | | | | | | | | | | | | | | |
5/26/23 12:23 | 5/24/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P.m | 1 | 1.59 | 0 | 1 | 0 | 1,021 | D | | | | | | | | | | | | | | |
5/22/23 18:47 | 5/18/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -147 | 97.93 | 0 | -2 | -2 | 92 | D | | | | | | | | | | | | | | |
5/22/23 17:00 | 5/18/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.dm | 1,591 | 79.54 | 0 | 20 | 3 | 597 | D | | | | | | | | | | | | | | |